Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. NVDA
2. SPY
3. GNK
4. PLUR
5. SPCX
6. AZN
7. FNGR
8. GSAT
9. S
10. AGPU

Go back to Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)

Zentalis Pharmaceuticals (ZNTL) Announces FDA Lifted Partial Clinical Hold on Azenosertib Studies

September 16, 2024 7:01 AM EDT

Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small... More